Will Retatrutide (new obesity drug) be FDA approved by the end of 2024?
6
189
Ṁ456Ṁ130
2025
4%
chance
1D
1W
1M
ALL
Get Ṁ600 play money
Sort by:
Phase 3 trial is estimated to complete in late 2025: https://classic.clinicaltrials.gov/ct2/show/NCT05882045
@jskf Thanks. I hadn’t seen that. I’ve made two more markets for end of 2025 and 2026.
More related questions
Related questions
Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?
46% chance
Will AOH1996 be FDA approved before 2040?
44% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
73% chance
Affordable weight loss drugs before 2030?
60% chance
Will aducanumab be withdrawn by the FDA by 2025?
44% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
63% chance
Will an AI-designed drug get FDA approval by the end of 2025?
33% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
43% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
68% chance
The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.
27% chance